The economic impact of tacrine in the treatment of Alzheimer's disease
- 30 April 1997
- journal article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 19 (2), 330-345
- https://doi.org/10.1016/s0149-2918(97)80121-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Long-term tacrine (Cognex) treatmentNeurology, 1996
- THE DARK SIDE OF CARING: Challenges of CaregivingJournal of Gerontological Nursing, 1995
- Tacrine for Alzheimer??s DiseasePharmacoEconomics, 1995
- The US economic and social costs of Alzheimer's disease revisited.American Journal of Public Health, 1994
- A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study GroupPublished by American Medical Association (AMA) ,1994
- The Economic Burden of Alzheimer's Disease CareHealth Affairs, 1993
- Out of Pocket Expenditures by Family Caregivers of Dementia Patients Residing in the CommunityHome Health Care Services Quarterly, 1992
- Estimated Prevalence of Alzheimer's Disease in the United StatesThe Milbank Quarterly, 1990
- The economic costs of Alzheimer's disease.American Journal of Public Health, 1987
- Evaluation of the Costs of Caring for the Senile Demented Elderly: A Pilot StudyThe Gerontologist, 1986